Search

Search Results
Results 981 - 990 of 1093 for Diabetes Type II
  • Norwegian government task force suggests formation of single company to commercialise biomaterial assets
    News - 18 Feb 2010
    Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets...
  • Merck announces global sales of $27.4 billion for full-year 2009
    News - 16 Feb 2010
    Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov....
  • Cymbalta (duloxetine HCl) shown to delay new episodes of depression
    News - 14 Dec 2008
    New data suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily delayed the onset of a new episode of depression in patients who had previously responded to the medication and who had...
  • Iptam
    Drug - 10 Apr 2025
    Consumer Medicine Information (CMI) about Iptam (sumatriptan) intended for persons living in Australia.
  • Axit
    Drug - 2 Apr 2025
    Consumer Medicine Information (CMI) about Axit intended for persons living in Australia.
  • Olsetan
    Drug - 12 Mar 2025
    Consumer Medicine Information (CMI) about Olsetan intended for persons living in Australia.
  • Velsipity
    Drug - 9 Jan 2025
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Iscover
    Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Iscover intended for persons living in Australia.
  • Cilatil
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • Lorstat (New Formulation)
    Drug - 11 Dec 2024
    Consumer Medicine Information (CMI) about Lorstat (New Formulation) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback